ProVise Management Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$9.15M Buy
23,524
+3,277
+16% +$1.27M 0.72% 46
2025
Q1
$8.81M Buy
20,247
+3,104
+18% +$1.35M 0.75% 46
2024
Q4
$6.32M Sell
17,143
-4,665
-21% -$1.72M 0.54% 52
2024
Q3
$11.3M Buy
21,808
+606
+3% +$315K 0.9% 32
2024
Q2
$11.5M Buy
21,202
+433
+2% +$235K 0.98% 31
2024
Q1
$10.8M Buy
20,769
+1,805
+10% +$936K 0.93% 34
2023
Q4
$8.94M Buy
18,964
+2,195
+13% +$1.04M 0.76% 39
2023
Q3
$7.3M Buy
16,769
+12,913
+335% +$5.62M 0.68% 44
2023
Q2
$1.71M Buy
3,856
+22
+0.6% +$9.77K 0.16% 136
2023
Q1
$1.76M Sell
3,834
-450
-11% -$207K 0.17% 124
2022
Q4
$2.2M Sell
4,284
-1,692
-28% -$868K 0.22% 113
2022
Q3
$2.72M Sell
5,976
-640
-10% -$291K 0.3% 92
2022
Q2
$3.19M Sell
6,616
-853
-11% -$412K 0.34% 86
2022
Q1
$3.67M Sell
7,469
-392
-5% -$193K 0.35% 83
2021
Q4
$3.64M Sell
7,861
-55
-0.7% -$25.5K 0.33% 84
2021
Q3
$2.95M Sell
7,916
-80
-1% -$29.8K 0.29% 97
2021
Q2
$3.05M Sell
7,996
-107
-1% -$40.9K 0.31% 89
2021
Q1
$2.91M Buy
8,103
+1,023
+14% +$367K 0.31% 96
2020
Q4
$2.27M Buy
7,080
+668
+10% +$214K 0.26% 100
2020
Q3
$1.72M Buy
6,412
+3,927
+158% +$1.05M 0.23% 107
2020
Q2
$654K Buy
2,485
+206
+9% +$54.2K 0.09% 163
2020
Q1
$517K Buy
2,279
+330
+17% +$74.9K 0.09% 169
2019
Q4
$589K Buy
1,949
+60
+3% +$18.1K 0.07% 187
2019
Q3
$454K Buy
1,889
+115
+6% +$27.6K 0.06% 203
2019
Q2
$501K Buy
+1,774
New +$501K 0.07% 203
2018
Q3
Sell
-20
Closed -$4.76K 328
2018
Q2
$4.76K Buy
+20
New +$4.76K 0.36% 68